Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.

Kim HS, Kim GY, Lim SJ, Park YK, Kim YW.

Hum Pathol. 2010 Nov;41(11):1609-16. doi: 10.1016/j.humpath.2010.04.012. Epub 2010 Aug 4.

PMID:
20688353
2.

Expression of p16 protein in gallbladder carcinoma and its precancerous conditions.

Choi HJ, Yun SS, Kim HJ, Choi JH.

Hepatogastroenterology. 2010 Jan-Feb;57(97):18-21.

PMID:
20422865
3.

Heparanase expression in gallbladder carcinoma and its correlation to prognosis.

Wu W, Pan C, Yu H, Gong H, Wang Y.

J Gastroenterol Hepatol. 2008 Mar;23(3):491-7. Epub 2007 May 24.

PMID:
17524042
4.
5.

Expression of Raf-1 kinase inhibitory protein in carcinoma of the ampulla of Vater.

Kim HS, Lee SH, Won KY, Kim GY, Park YK, Kim YW.

Virchows Arch. 2012 Jan;460(1):61-8. doi: 10.1007/s00428-011-1174-y. Epub 2011 Nov 20.

PMID:
22102065
6.

Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.

Xiong L, Yang Z, Yang L, Liu J, Miao X.

J Surg Oncol. 2012 Jan;105(1):97-103. doi: 10.1002/jso.22055. Epub 2011 Aug 3.

PMID:
21815153
7.

The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.

da Rocha AO, Coutinho LM, Scholl JG, Leboutte LD.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1310-4.

PMID:
15362740
8.

Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.

Chijiiwa K, Nakano K, Ueda J, Noshiro H, Nagai E, Yamaguchi K, Tanaka M.

J Am Coll Surg. 2001 May;192(5):600-7.

PMID:
11333097
9.
10.

Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray.

Li SH, Li CF, Sung MT, Eng HL, Hsiung CY, Huang WW, Lin CN, Yu SC, Huang HY.

Mod Pathol. 2007 Apr;20(4):497-507. Epub 2007 Mar 2.

11.

Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions.

Xiong L, Deng X, Wen Y, Yang Z, Miao X.

World J Surg Oncol. 2013 Mar 26;11:80. doi: 10.1186/1477-7819-11-80.

13.

Expression of the GLUT1 glucose transporter in gallbladder carcinomas.

Kim YW, Park YK, Yoon TY, Lee SM.

Hepatogastroenterology. 2002 Jul-Aug;49(46):907-11.

PMID:
12143238
14.

RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer.

Oshikiri T, Hida Y, Miyamoto M, Hashida H, Katoh K, Suzuoki M, Nakakubo Y, Hiraoka K, Shinohara T, Itoh T, Kondo S, Katoh H.

Br J Cancer. 2001 Dec 14;85(12):1922-7.

15.

Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.

Liu DC, Yang ZL.

Hum Pathol. 2011 Nov;42(11):1676-83. doi: 10.1016/j.humpath.2010.12.026. Epub 2011 May 2.

PMID:
21543106
16.

Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.

Shu GS, Lv F, Yang ZL, Miao XY.

Int J Clin Oncol. 2013 Aug;18(4):641-50. doi: 10.1007/s10147-012-0431-7. Epub 2012 Jun 21.

PMID:
22714709
17.

Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer.

Quan ZW, Wu K, Wang J, Shi W, Zhang Z, Merrell RC.

J Am Coll Surg. 2001 Oct;193(4):380-3.

PMID:
11584965
18.

L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma.

Choi SY, Jo YS, Huang SM, Liang ZL, Min JK, Hong HJ, Kim JM.

Hum Pathol. 2011 Oct;42(10):1476-83. doi: 10.1016/j.humpath.2011.01.003. Epub 2011 Apr 14.

PMID:
21496863
19.

Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma.

Leal P, García P, Sandoval A, Letelier P, Brebi P, Ili C, Álvarez H, Tapia O, Roa JC.

Arch Pathol Lab Med. 2013 Apr;137(4):552-7. doi: 10.5858/arpa.2012-0032-OA.

PMID:
23544944
20.

Supplemental Content

Support Center